337 related articles for article (PubMed ID: 16684804)
1. Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.
Willsky GR; Chi LH; Liang Y; Gaile DP; Hu Z; Crans DC
Physiol Genomics; 2006 Aug; 26(3):192-201. PubMed ID: 16684804
[TBL] [Abstract][Full Text] [Related]
2. Improvement of impaired glucose tolerance by oral administration of vanadyl sulfate by gavage in streptozotocin-induced diabetic rats.
Tsunajima T; Tatsuki R; Satoh K; Yamamoto A; Hoshi K; Ichihara K
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):190-200. PubMed ID: 9467827
[TBL] [Abstract][Full Text] [Related]
3. Improvement of diabetic states in streptozotocin-induced type 1 diabetic rats by vanadyl sulfate in enteric-coated capsules.
Fugono J; Yasui H; Sakurai H
J Pharm Pharmacol; 2005 May; 57(5):665-9. PubMed ID: 15901357
[TBL] [Abstract][Full Text] [Related]
4. Influence of vanadium supplementation on oxidative stress factors in the muscle of STZ-diabetic rats.
Kurt O; Ozden TY; Ozsoy N; Tunali S; Can A; Akev N; Yanardag R
Biometals; 2011 Oct; 24(5):943-9. PubMed ID: 21479831
[TBL] [Abstract][Full Text] [Related]
5. Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats.
Tunali S; Yanardag R
Pharmacol Res; 2006 Mar; 53(3):271-7. PubMed ID: 16431126
[TBL] [Abstract][Full Text] [Related]
6. Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems.
Tas S; Sarandol E; Ayvalik SZ; Serdar Z; Dirican M
Arch Med Res; 2007 Apr; 38(3):276-83. PubMed ID: 17350476
[TBL] [Abstract][Full Text] [Related]
7. Conformation changes in brain calcineurin in diabetic rats with or without treatment with vanadyl sulfate.
Li H; Wei Q
IUBMB Life; 2001 Jun; 51(6):373-6. PubMed ID: 11758805
[TBL] [Abstract][Full Text] [Related]
8. Decrease of hypothalamic neuropeptide Y gene expression by vanadyl sulfate in streptozotocin-induced diabetic rats.
Liu IM; Chi TC; Cheng JT
Horm Metab Res; 2001 Feb; 33(2):96-100. PubMed ID: 11294500
[TBL] [Abstract][Full Text] [Related]
9. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
Xie M; Gao L; Li L; Liu W; Yan S
J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
Bolkent S; Bolkent S; Yanardag R; Tunali S
Diabetes Res Clin Pract; 2005 Nov; 70(2):103-9. PubMed ID: 16188572
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
Yao J; Battell ML; McNeill JH
Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
[TBL] [Abstract][Full Text] [Related]
12. Administration of vanadyl sulfate by gavage does not normalize blood glucose levels in streptozotocin-induced diabetic rats.
Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):369-72. PubMed ID: 1509205
[TBL] [Abstract][Full Text] [Related]
13. Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats.
Li M; Smee JJ; Ding W; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):585-9. PubMed ID: 19203797
[TBL] [Abstract][Full Text] [Related]
14. Oral insulin-mimetic compounds that act independently of insulin.
García-Vicente S; Yraola F; Marti L; González-Muñoz E; García-Barrado MJ; Cantó C; Abella A; Bour S; Artuch R; Sierra C; Brandi N; Carpéné C; Moratinos J; Camps M; Palacín M; Testar X; Gumà A; Albericio F; Royo M; Mian A; Zorzano A
Diabetes; 2007 Feb; 56(2):486-93. PubMed ID: 17259395
[TBL] [Abstract][Full Text] [Related]
15. Insulin sensitivity in streptozotocin-induced diabetic rats treated with different doses of 17beta-oestradiol or progesterone.
Ordóñez P; Moreno M; Alonso A; Fernández R; Díaz F; González C
Exp Physiol; 2007 Jan; 92(1):241-9. PubMed ID: 17068109
[TBL] [Abstract][Full Text] [Related]
16. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
Colombo M; Kruhoeffer M; Gregersen S; Agger A; Jeppesen P; Oerntoft T; Hermansen K
Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918
[TBL] [Abstract][Full Text] [Related]
17. Vanadyl sulfate protects against streptozotocin-induced morphological and biochemical changes in rat aorta.
Akgün-Dar K; Bolkent S; Yanardag R; Tunali S
Cell Biochem Funct; 2007; 25(6):603-9. PubMed ID: 16892454
[TBL] [Abstract][Full Text] [Related]
18. Effects of vanadyl sulfate on kidney in experimental diabetes.
Yanardag R; Bolkent S; Karabulut-Bulan O; Tunali S
Biol Trace Elem Res; 2003 Oct; 95(1):73-85. PubMed ID: 14555801
[TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
20. Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats.
Koyuturk M; Tunali S; Bolkent S; Yanardag R
Biol Trace Elem Res; 2005 Jun; 104(3):233-47. PubMed ID: 15930593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
